A research study titled, Wearable Injectors Market by Technology, Type, Application and End User - Global Industry Analysis and Forecast to
2025” published by Crystal Market Research, states that the wearable injectors
market is projected to be around $14 billion by 2025.
Wearable injectors are also known as large volume injector
which helps in administering large volumes of drug via subcutaneous route. They
are faster means of drug delivery and are self-administered. Wearable injectors
provide reduced dosing frequency and improve safety, efficacy, convenience and
tolerability. Wearable injectors are connected to body with an infusion set or
directly attached to the skin. It is necessary to consider physiology of skin
before attaching the wearable injectors to the skin. They also avoid systemic
effects such as headache, fever and nausea. Wearable injectors are gaining
importance as they are prefilled and fully disposable. They also offer easy
adherence to skin. They are generally used to deliver in 2-10 ml dose volumes.
Wearable injectors reduce the necessity to visit the hospital. Wearable
injectors offer convenience of usage and improved patient compliance. Wearable
injectors are used in treatment of cardiovascular diseases, infectious
diseases, and autoimmune disorder, cancer and blood disorders. Wearable
injectors are of two types, namely, off-body worn belt injector and body-worn
patch injector. In off-body worn belt injector, an adhesive is used to connect
the device with the skin of patient. Off-body worn belt injector can be used to
deliver volumes up to 20 ml. Body-worn patch injector uses a needle which
automatically injects and retracts. It can be used to deliver volumes above 20
ml.
Get Free Sample of this Report@: https://www.crystalmarketresearch.com/report-sample/HC06164
The major driver for the growth of global wearable
injectors market is the advancements in the technology such as wearable
injectors integrated with Bluetooth. With the help of this technological
advancement, patients can get injection reminders and data regarding their
therapy regime. Another factor driving this market is the benefit of wearable
injectors such as large volume dose administration and requirement of subcutaneous
injection over conventional injectors. Moreover, increasing prevalence of
cancer will also fuel the growth of this market. For instance, according to
American Cancer Society, in U.S., about 14.5 million people were suffering from
cancer. Furthermore, increase in the biologics market is set to drive the
market.
The key strategy followed by the major players in the
market is collaborations to gain more share. For instance, in October 2014,
Unilife Corporation signed a Master Services and Commercial Supply Agreement
with Sanofi and became the sole provider of cartridge-based wearable injector
systems for Sanofi’s large dosage volume drugs for a minimum period of 15 years
except for insulin. This agreement helped Unilife to expand the reach of its wearable
injectors to new global markets. Some of major players operating in the global
wearable injectors market are, Amgen
Inc., Enable Injections, Inc., Insulet Corporation, West Pharmaceutical
Services, Inc., Becton, Dickinson and Company, Ypsomed AG, Unilife Corporation
and Sensile Medical AG.
Browse full research report with TOC on “Wearable
Injectors Market by Technology, Type, Application and End User - Global
Industry Analysis and Forecast to 2025” at:
Competitive Analysis
The key players operating in the global
wearable injectors market emphasize on strategic collaborations to strengthen
their product portfolio and ensure a larger share of the market. For
instance, in February 2016, Unilife Corporation collaborated with Amgen Inc.
for injectable drug delivery systems. In this collaboration, Unilife
Corporation has granted Amgen Inc., the rights for Unilife’s prefilled,
customizable wearable injectors. Some of the key players operating in this
market are, Amgen Inc., Enable
Injections, Inc., Insulet Corporation, West Pharmaceutical Services, Inc.,
Becton, Dickinson and Company, Ypsomed AG, Unilife Corporation and Sensile
Medical AG.
About Crystal Market Research
Crystal
Market Research is a U.S. based market research and business intelligence
company. Crystal offers one stop solution for market research, business
intelligence, and consulting services to help clients make more informed
decisions. It provides both syndicated as well as customized research studies
for its customers spread across the globe. The company offers market
intelligence reports across a broad range of industries including healthcare,
chemicals & materials, technology, automotive, and energy.
Contact Us:
304
South Jones Blvd, Suite 1896,
Las
Vegas NV 89107,
United
States
Toll Free:
+ 1-888-213-4282
Email:
sales@crystalmarketresearch.com
No comments:
Post a Comment